GL1X · GenesisL1 explorer

MolNFT v1 · #116948 · protein

Crystal structure of dfp-inhibited mouse acetylcholinesterase in complex with the reactivator sp-134

5DTJ: “Crystal structure of dfp-inhibited mouse acetylcholinesterase in complex with the reactivator sp-134”. X-ray diffraction, 1 ligand (5G8), 13 pockets (best druggability 0.82). MolNFT v1 #116948 on GenesisL1: 3D structure, binding…

PDB
5DTJ
Type
protein
Length
1,069 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Acetylcholinesterase
EC
3.1.1.7
UniProt
P21836
Ligands
5G8
Pockets
13 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 39% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAcetylcholinesterase (EC 3.1.1.7)protein53738% helix, 18% strandP21836
BAcetylcholinesterase (EC 3.1.1.7)protein53239% helix, 18% strandP21836

Ligands and binding sites

  • 5G8 · 1-[5-(2,4-dichlorophenoxy)pentyl]-1H-imidazole · ligand · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13460.820.92455G8
23570.800.90455G8
32520.660.8337empty
41760.600.8218empty
51930.590.8221empty

Interfaces

1 interface between chains.

  • A–B · 919 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 2 modified (disulfide, nonstandard).

Compared structures

  • 5DTJ · Crystal Structure of dfp-inhibited mouse acetylcholinesterase in complex with the… · the same entry in another collection · chain A against A, TM-score 1.00
  • P21836 · AlphaFold monomer V2.0 prediction for acetylcholinesterase (P21836) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.